OSCR Form 4: CTO exercised 555,165 options and executed sell-to-cover of 395,000 shares
Rhea-AI Filing Summary
Oscar Health insider filings show option exercise and share sale by Mario Schlosser. Mr. Schlosser exercised 555,165 vested stock options with a $6.36 exercise price on 09/22/2025, creating the right to 555,165 Class A shares. Concurrently he converted and sold 395,000 Class A shares in multiple transactions at a weighted average price of $18.43 to cover the exercise cost and tax withholding, leaving him with 501,148 Class A shares beneficially owned. Certain remaining shares are held indirectly in family dynasty trusts over which he disclaims beneficial ownership except for any pecuniary interest.
Positive
- Large vested option exercised (555,165 options), indicating prior compensation vesting and potential management retention alignment
- Comprehensive disclosure including sale price range, purpose (cover exercise and tax withholding), option expiry date, and trust holdings
Negative
- Sale of 395,000 shares reduced directly held Class A shares, which may modestly increase available float
- Substantial number of options and shares remain exercisable or convertible, representing potential future dilution
Insights
TL;DR: Director exercised a large, fully vested option package and sold shares to satisfy exercise and tax obligations; ownership remains significant.
The filing documents a routine but sizable option exercise and related sell-to-cover transactions. Exercise price of $6.36 versus sale-weighted price $18.43 implies a realized spread per sold share, with 395,000 shares sold to fund costs and withholding. Post-transaction direct beneficial ownership of Class A shares is 501,148, and combined direct plus convertible Class B rights total materially higher, indicating continued alignment with company equity despite liquidity events.
TL;DR: Disclosure is complete and standard: vested options exercised, multiple trust holdings noted, and sale explained as tax/expense coverage.
The Form 4 discloses conversion mechanics of Class B to Class A shares, expiration date of the option (12/07/2025), and trust holdings with disclaimer of beneficial ownership except for pecuniary interest. The reporting and explanatory footnotes conform to Section 16 transparency expectations and identify that the sale was effected in multiple transactions at prices between $18.25 and $18.78.